The results presented in this manuscript provide critical molecular and biological insights into the role of the PKIB, an endogenous PKA inhibitor, in tumors, as an oncogene and a driver of tumor cell proliferation and invasion in BLCA. The gene discussed is PKIB; the disease is bladder transitional cell carcinoma.